Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
life sciences
national blog main
new york blog main
amgen
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
detroit blog main
detroit top stories
eli lilly
eptinezumab
erenumab
fda
fremanezumab
galcanezumab
indiana blog main
indiana top stories
migraine research foundation
national
national top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
alder biopharmaceuticals
What
class
3
×
new
approval
drug
fda
medicines
migraine
won
amgen
arguments
based
begin
big
biosciences
bio’s
brings
bubbles
candidates
cells
clinical
codiak
commercialized
companies
competitors
decades
developed
drugs
exosome
exosomes
formed
fund
gets
head
ipo
make
meeting
million
neuro
nod
oral
Language
unset
Current search:
class
×
" boston blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
